ANI Pharmaceuticals
ANIP
#5255
Rank
NZ$2.84 B
Marketcap
NZ$125.31
Share price
-0.84%
Change (1 day)
-12.77%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): NZ$9.07

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$9.47. In 2025 the company made an earnings per share (EPS) of NZ$6.40 an increase over its 2024 EPS that were of NZ-$2.05.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$9.0741.77%
2025NZ$6.40-412.5%
2024NZ-$2.05
2022NZ-$5.56-6.46%
2021NZ-$5.9472.87%
2020NZ-$3.44-476%
2019NZ$0.91-62.12%
2018NZ$2.41
2015NZ$2.45-47.66%
2014NZ$4.68-142.11%
2013NZ-$11.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.60 1.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.30-86.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$14.19 49.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$6.64-29.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
NZ-$4.61-148.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.95-183.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$0.82-91.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
NZ$2.80-70.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
NZ-$46.21-588.03%๐Ÿ‡บ๐Ÿ‡ธ USA